In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animals

Blood

Volumn 102, Issue 3, 2003, Pages 843-848

  McCauslin, Christine S ^c   Wine, John ^c   Cheng, Linzhao ^c   Klarmann, Kim D ^c   Candotti, Fabio ^c   Clausen, Peter A ^c   Spence, Sally E ^a   Keller, Jonathan R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; HEMOPOIETIC GROWTH FACTOR; JANUS KINASE 3; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; COLONY FORMING UNIT; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; KNOCKOUT MOUSE; LYMPHOCYTE SUBPOPULATION; MICROENVIRONMENT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RETROVIRUS INFECTION; SIGNAL TRANSDUCTION; TARGET CELL; VIRAL GENE DELIVERY SYSTEM;

EID: 0042243666     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-12-3859     Document Type: Article

References (37)

1. Williams DA, Lemischka IR, Nathan DG, Mulligan RC. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature. 1984;310:476-480.
2. Dick JE, Magli MC, Huszar D, Phillips RA, Bernstein A. Introduction of a selectable gene into primitive stem cells capable of long term reconstruction of the hemopoietic system of W/Wv mice. Cell. 1985;42:71-79.
3. Keller G, Paige C, Gilboa E, Wagner EF. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature. 1985;318:149-154.
4. Roe T, Reynolds TC, Yu G, Brown PO. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 1993;12:2099-2108.
5. Zipori D. The renewal and differentiation of hemopoietic stem cells. FASEB J. 1992;6:2691-2697.
6. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993;81:2844-2853.
7. Germeraad WTV, Asami N, Fujimoto S, Mazda O, Katsura Y. Efficient retrovirus mediated gene transduction into murine hematopoietic stem cells and long lasting expression using a transwell co-culture system. Blood. 1994;84:780-788.
8. Halene S, Wang L, Cooper RM, Bockstoce DC, Robbins PB, Kohn DB. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood. 1999;94:3349-3357.
9. Cavazzana-Calvo M, Hacein-Bey S, Basile GDS, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288:669-672.
10. Abonour R, Williams DA, Einhorn L, et al. Efficient retrovirus mediated transfer of the multidrug resistance 1 gene into autologous human long term repopulating hematopoietic stem cells. Nat Med. 2000;6:652-658.
11. Tavassoli M, Hardy CL. Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood. 1990;76:1059-1070.
12. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ. Murine marrow cells expanded in culture with IL-3, IL-6, and SCF acquire an engraftment defect in normal hosts. Exp Hematol. 1995; 23:461-469.
13. Yonemura Y, Ku H, Hairayama F, Souza LM, Ogawa M. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci U S A. 1996;93:4040-4044.
14. Holyoake TL, Alcorn MJ, Richmond L, et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant. 1997;19:1095-1101.
15. Varas F, Bernad A, Bueren JA. Restrictions in stem cell function of murine bone marrow grafts after ex vivo expansion of short term repopulating progenitors. Exp Hematol. 1998;26:100-109.
16. Szilvassy SJ, Bass MJ, Zant GV, Grimes B. Organ selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood. 1999; 93:1557-1566.
17. Allay JA, Galipeau J, Blakley RL, Sorrentino BP. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells. Stem Cells. 1998;16:223-233.
18. Battaile KP, Bateman RL, Mortimer D, et al. In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. Blood. 1999;94:2151-2158.
19. Bunting KD, Lu T, Kelly PF, Sorrentino BP. Self selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation. Hum Gene Ther. 2000;11:2353-2364.
20. Bunting KD, Sangster MY, Ihle JN, Sorrentino BP. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral mediated gene transfer. Nat Med. 1998;4:58-64.
21. Bunting KD, Flynn KJ, Riberdy JM, Doherty PC, Sorrentino BP. Virus specific immunity after gene therapy in a murine model of severe combined immunodeficiency. Proc Natl Acad Sci U S A. 1999;96:232-237.
22. Otsu M, Sugamura K, Candotti F. Lack of dominant-negative effects of a truncated gamma(c) on retroviral-mediated gene correction of immunodeficient mice. Blood 2001;97:1618-1624.
23. Nosaka T, Deursen JMAV, Tripp TA, et al. Defective lymphoid development in mice lacking Jak3. Science. 1995;270:800-802.
24. Park SY, Saijo K, Takeahashi T, et al. Developmental defects of lymphoid cells in Jak3 kinase deficient mice. Immunity. 1995;3:771-782.
25. Noguchi M, Nakamura Y, Russell SM, et al. Interleukin-2 receptor gamma chain: a functional com ponent of the interleukin-7 receptor. Science. 1993;262:1877-1880.
26. Baird AM, Thomis DC, Berg LJ. T cell development and activation in Jak3-deficient mice. J Leukoc Biol. 1998;63:669-677.
27. Macchi P, Villa A, Giliani S, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature. 1995;377:65-68.
28. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology. 1988;167:400-406.
29. Cheng L, Du C, Murray D, et al. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther. 1997;4:1013-1022.
30. Ogawa M, Shih JP, Katayama N. Enrichment for primitive hemopoietic progenitors of marrow cells from 5-fluorouracil treated mice and normal mice. Blood Cells. 1994;20:7-13.
31. Harrison DE, Lerner CP. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood. 1991; 78:1237-1240.
32. Robbins PB, Skelton DC, Yu X-J, Halen S, Leonard EH. Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc Natl Acad Sci U S A. 1998;95:10182-10187.
33. Nelson DM, Metzger ME, Donahue RE, Morgan RA. In vivo retrovirus mediated gene transfer into multiple hematopoietic lineages in rabbits without preconditioning. Hum Gene Ther. 1997;8:747-754.
34. Porada CD, Tran ND, Zhao Y, Anderson WF, Zanjani ED. Neonatal gene therapy: transfer and expression of exogenous genes in neonatal sheep following direct injection of retroviral vectors into the bone marrow space. Exp Hematol. 2000;28:642-650.
35. Rosenzweig M, MacVittie TJ, Harper D, et al. Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood. 1999;94:2271-2286.
36. Tisdale JF, Hanazono Y, Sellers SE, et al. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long term repopulating ability. Blood. 1998;92:1131-1141.
37. Marshall E. News: gene therapy a suspect in leukemia-like disease. Science. 2002;298:34-35.